Citation Impact
Citing Papers
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Cell‐Based Assays Using Primary Endothelial Cells to Study Multiple Steps in Inflammation
2006 StandoutNobel
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
Gastric cancer
2016 Standout
Parenteral Anticoagulants
2012 Standout
Immunosuppression in renal transplantation II. Corticosteroids, antilymphocyte globulin, and OKT3
1991
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
2004 Standout
Chemotherapy for advanced gastric cancer: ongoing phase III study of S-1 alone versus S-1 and docetaxel combination (JACCRO GC03 study)
2008
Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality
1999
Induction of oesophageal and forestomach carcinomas in rats by reflux of duodenal contents
1994
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
2006 Standout
The multitude and diversity of environmental carcinogens
2007 StandoutNobel
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics
2006
Does protamine chloride neutralize low molecular weight heparin sufficiently?
1988
Elective Splenectomy in Children With Idiopathic Thrombocytopenic Purpura
2000
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Chemotherapy for advanced gastric cancer
2010
A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer
2002
Chemotherapy for advanced gastric cancer
2005
Predictive factors for successful laparoscopic splenectomy in immune thrombocytopenic purpura
2006
Hydrogel nanoparticles in drug delivery
2008 Standout
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
1996 Standout
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
2005 Standout
Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation
1998 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Publication and related bias in meta-analysis
2000 Standout
Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer
2001
Inflammation and Colon Cancer
2010 Standout
The Bleeding Risk and Natural History of Idiopathic Thrombocytopenic Purpura in Patients With Persistent Low Platelet Counts
2000
A month–long effect from a single injection of microencapsulated human growth hormone
1996
Sulindac Inhibits Activation of the NF-κB Pathway
1999
Immune Thrombocytopenic Purpura
2002 Standout
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
A 5‐decade analysis of 13,715 carcinoid tumors
2003 Standout
Laparoscopic splenectomy in chronic idiopathic thrombocytopenic purpura
2000
Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) Results of Protocol E1293
1996
Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells
1998 Standout
Prevention of Venous Thromboembolism
2004 Standout
Heparin and Low-Molecular-Weight Heparin
1998
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
1999 Standout
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
1999 Standout
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
2008 Standout
Management of Immune Thrombocytopenic Purpura in Adults
2004
Non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention
2003
Postoperative pancreatic fistula: An international study group (ISGPF) definition
2005 Standout
Function-Preserving Gastrectomy for Early Gastric Cancer
2013
Gastric cancer
2020 Standout
Prevention of Venous Thromboembolism
2008 Standout
An analysis of 8305 cases of carcinoid tumors
2000 Standout
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices
2000 Standout
Pathophysiological effects of long-term acid suppression in man
1995
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
1997 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
2008 Standout
Immune thrombocytopenic purpura in adults
2007
Nonsteroidal anti-inflammatory drugs and colorectal cancer: Evolving concepts of their chemopreventive actions
1997
Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis
1988
Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis
1992
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
The Rate of Bleeding Complications After Pharmacologic Deep Venous Thrombosis Prophylaxis
2006
Pharmacotherapeutic Aspects of Unfractionated and Low Molecular Weight Heparins
1990
The Delphi List
1998 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer
1997
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
Effects of sulindac on sporadic colorectal adenomatous polyps.
1997
Low molecular weight heparin in prevention of perioperative thrombosis.
1992
Heparins and mechanical methods for thromboprophylaxis in colorectal surgery
2003
Causal role ofHelicobacter pyloriinfection in gastric cancer
2006
Low Molecular Weight Heparin Therapy: Is Monitoring Needed?
1994
Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group
2006 Standout
Polymeric Systems for Controlled Drug Release
1999 Standout
Chemotherapy for advanced gastric cancer
2017 Standout
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
Risk of Gastric Cancer After Gastric Surgery for Benign Disorders
1990
Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis
1988
Prophylaxis of postoperative thromboembolism with low molecular weight heparins
1993
Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: A co-operative study
1985
A Randomized Double-Blind Study Between a Low Molecular Weight Heparin Kabi 2165 and Standard Heparin in the Prevention of Deep Vein Thrombosis in General Surgery
1988
Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery
1988
CYCLOOXYGENASES 1 AND 2
1998 StandoutNobel
The Stabilization and Encapsulation of Human Growth Hormone into Biodegradable Microspheres
1997
Low molecular weight heparin once daily compared with conventional low-dose heparin twice daily. A prospective double-blind multicentre trial on prevention of postoperative thrombosis
1986
Low-Molecular-Weight Heparins
1997 Standout
Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications
2004
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
High Doses of 5-Fluorouracil and Epirubicin with or without Cisplatin in Advanced Gastric Cancer: A Randomized Study
1999
Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration
1985
Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: Update of previous meta-analyses
1997
Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: a systematic review of randomized controlled trials
2001
New advances in microsphere-based single-dose vaccines
1997
Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteers
1986
Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery
2001
Works of H. Bünte being referenced
Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment
1995
Chemotherapy of gastric cancer
1988
Clinical and functional results of abdominal rectopexy with absorbable mesh-graft for treatment of complete rectal prolapse.
1993
[Somatostatin in pancreas and small intestine fistulas].
1984
Clinical efficacy of low molecular weight heparin in postoperative thrombosis prophylaxis
1984
Results and prognostic factors of splenectomy in idiopathic thrombocytopenic purpura.
1996
Use of Orthoclone OKT3 as treatment of acute renal allograft rejection and as first-line therapy in kidney transplantation.
1988
Morphological changes in the operated stomach under the influence of duodenogastric reflux. Clinical follow-up over 20 years.
1984
Operation‐sequel carcinoma of the stomach. Experimental studies of surgical techniques with or without resection
1981
The influence of caecostomy and colonic irrigation on pathophysiology and prognosis in acute experimental pancreatitis.
1993